Skip navigation

300431: Medicaments containing insulin, put up in measured doses/forms/packings for RS

COMESA

Goods are considered originating if they have been produced in the member States wholly or partially from materials imported from outside the member States or of undetermined origin provided that:

  • The c.i.f. value of those materials does not exceed 60% of the total cost of the materials used in the production of the goods;
  • The value added resulting from the process of production accounts for at least 25% of the ex-factory cost of the goods;
  • xManufacture from materials classified in a heading other than that of the product, except from materials of heading 30.03
Calculate fulfilment

SADC

  • Manufacture in which all the materials used are classified within a heading other than that of the product
Calculate fulfilment

EAC

Goods are considered originating if they have been produced in the member States wholly or partially from materials imported from outside the member States or of undetermined origin provided that:

  • The c.i.f. value of those materials does not exceed 60% of the total cost of the materials used in the production of the goods;
  • The value added resulting from the process of production accounts for at least 35% of the ex-factory cost of the goods;
  • Manufacture from materials classified within a heading other than that of the product, except from materials of heading 30.03. - This excludes the process of mixing and putting up in measured doses or in forms or packing for retail sale. up in measured
Calculate fulfilment

EU GSP

Exception: Medicaments (excluding goods of heading 3002, 3005 or 3006) obtained from amikacin of heading 2941

Exception: Products of heading 3004 that are not obtained from amikacin of heading 2941

References: